.
MergerLinks Header Logo

New Deal

New Deal

Cover Image James Foster
James FosterCHARLES RIVER LABORATORIES INTERNATIONAL INC

James Foster

President and CEO at CHARLES RIVER LABORATORIES INTERNATIONAL INC

Manager

Deal Bio

Total Deals11
Valued Deals10
Total Value£2,505M
Avg. Deal Size£251M
United States
Medical Equipment
PrivateAcquisitionMajority
Mpi Research

target

Mpi Research

Charles River Laboratories International

bidder

Charles River Laboratories International

£578m

9 dealmakers

United States
Biotechnology
PrivateAcquisition
CITOXLAB

target

CITOXLAB

Charles River Laboratories International

bidder

Charles River Laboratories International

£384m

6 dealmakers

United States
Medical Supplies
AcquisitionMajorityPublicDomestic
Hemacare Corporation

target

Hemacare Corporation

Charles River Laboratories International

bidder

Charles River Laboratories International

£252m

25 dealmakers

United States
Biotechnology
PrivateAcquisitionDomesticMajorityPrivate Equity
Cognate Bioservices

target

Cognate Bioservices

Charles River Laboratories International

bidder

Charles River Laboratories International

£628m

40 dealmakers

United StatesChina
Biotechnology
MajorityAcquisitionDomesticPrivatePrivate Equity
Vigene Biosciences

target

Vigene Biosciences

Charles River Laboratories International

bidder

Charles River Laboratories International

£248m

32 dealmakers

Sweden
Pharmaceuticals
MajorityVenture CapitalAcquisitionCross BorderPrivatePrivate Equity
Cobra Biologics Matfors

target

Cobra Biologics Matfors

Flerie Invest

bidder

Flerie Invest

£37m

6 dealmakers

United Kingdom
Biotechnology
PrivateAcquisitionMinorityCross BorderVenture CapitalPrivate Equity
BIT.BIO

target

BIT.BIO

Charles River Laboratories International

bidder

Charles River Laboratories International

£76m

8 dealmakers

United States
Biotechnology
MajorityAcquisitionDomesticPrivate
Explora Biolabs

target

Explora Biolabs

Charles River Laboratories International

bidder

Charles River Laboratories International

£224m

15 dealmakers

United Kingdom
Medical Equipment
PrivateAcquisitionCross BorderMajority
RETROGENIX

target

RETROGENIX

Charles River Laboratories International

bidder

Charles River Laboratories International

£35m

5 dealmakers

United States
Biotechnology
AcquisitionPrivateMajorityDomestic
Charles River (avian Vaccine Services Business)

target

Charles River (avian Vaccine Services Business)

Arlington Capital Partners

bidder

Arlington Capital Partners

value n/a

3 dealmakers

United States
Pharmaceuticals
AcquisitionMajorityDomesticPrivate
Samdi Tech

target

Samdi Tech

Charles River Laboratories International

bidder

Charles River Laboratories International

£40m

5 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US